INNOPHARMAX INC has a total of 70 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2007. It filed its patents most often in EPO (European Patent Office), Taiwan and China. Its main competitors in its focus markets pharmaceuticals, environmental technology and organic fine chemistry are PROCARE HEALTH IBERIA S L, RECEPTICON APS and GUANGXI HUAHONG PHARMACEUTICAL.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 8 | |
#2 | Taiwan | 7 | |
#3 | China | 6 | |
#4 | United States | 6 | |
#5 | Australia | 5 | |
#6 | Brazil | 5 | |
#7 | Canada | 5 | |
#8 | Republic of Korea | 5 | |
#9 | WIPO (World Intellectual Property Organization) | 5 | |
#10 | Mexico | 4 | |
#11 | Japan | 3 | |
#12 | Colombia | 2 | |
#13 | Israel | 2 | |
#14 | Singapore | 2 | |
#15 | EAPO (Eurasian Patent Organization) | 1 | |
#16 | Hong Kong | 1 | |
#17 | New Zealand | 1 | |
#18 | Russian Federation | 1 | |
#19 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology | |
#3 | Organic fine chemistry | |
#4 | Chemical engineering |
# | Name | Total Patents |
---|---|---|
#1 | Hao Wei-Hua | 46 |
#2 | Wang Jong-Jing | 38 |
#3 | Hsu Chang-Shan | 36 |
#4 | Lin Tsung-Hsin | 15 |
#5 | Yang Yu-Tsai | 9 |
#6 | Hsu Pei-Jing | 9 |
#7 | Wang Zhen | 8 |
#8 | Chen Hui-Yun | 8 |
#9 | Wang Weida | 8 |
#10 | Lan Jingbo | 8 |
Publication | Filing date | Title |
---|---|---|
AU2017273495A1 | Metronomic oral gemcitabine for cancer therapy | |
EP3215128A1 | Oral administration of unstable or poorly-absorbed drugs | |
MX2013012429A | A composition of entacopone. | |
TW201242596A | Entacapone composition | |
MX2013004092A | Preparation process of (6r)-tetrahydrobiopterin hydrochloride. | |
TW201215613A | Preparation process of (6r)-tetrahydrobiopterin hydrochloride | |
US2010273730A1 | Self-emulsifying pharmaceutical compositions of hydrophilic drugs and preparation thereof | |
TW201114419A | Pharmaceutical composition for parkinson's disease | |
TW200922637A | Pharmaceutical composition with enhanced bioavailability | |
US2009130198A1 | Pharmaceutical composition with enhanced bioavailability |